High-flow nasal cannula therapy for acute respiratory failure in patients with interstitial pneumonia: a retrospective observational study

1. Park IN, Kim DS, Shim TS, et al. Acute exacerbation of interstitial pneumonia other than idiopathic

pulmonary fibrosis. Chest. 2007;132(1):214–220.

2. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis: analysis

of clinical and pathologic findings in three cases. Chest. 1993;103(6):1808–1812.

3. Martinez FJ, Safrin S, Weycker D, et al; IPF Study Group. The clinical course of patients with idiopathic

pulmonary fibrosis. Ann Intern Med. 2005;21;142:963–967.

4. Silva CI, Müller NL, Fujimoto K, et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution

computed tomography and pathologic findings. J Thorac Imaging. 2007;22(3):221–229.

5. Churg A, Muller NL, Silva CI, et al. Acute exacerbation (acute lung injury of unknown cause) in UIP and

other forms of fibrotic interstitial pneumonias. Am J Surg Pathol. 2007;31(2):277–284.

6. Suda T, Kaida Y, Nakamura Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen

vascular diseases. Respir Med. 2009;103(6):846–853.

7. Olson AL, Huie TJ, Groshong SD, et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis. Chest.

2008;134(4):844–850.

8. Yokoyama T, Kondoh Y, Taniguchi H, et al. Noninvasive ventilation in acute exacerbation of idiopathic

pulmonary fibrosis. Intern Med. 2010;49(15):1509–1514.

9. Güngör G, Tatar D, Saltürk C, et al. Why do patients with interstitial lung diseases fail in the ICU? A

2-center cohort study. Respir Care. 2013;58(3):5255–5231.

10. Chanques G, Riboulet F, Molinari N, et al. Comparison of three high flow oxygen therapy delivery devices:

a clinical physiological cross-over study. Minerva Anestesiol. 2013;79:1344–1355.

11. Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high-flow

oxygen therapy. Respir Care. 2011;56:1151–1155.

12. Dysart K, Miller TL, Wolfson MR, et al. Research in high flow therapy: mechanisms of action. Respir

Med. 2009;103(10):1400–1405.

13. Frat JP, Thille AW, Mercat A, et al; FLORALI Study Group; REVA Network. High-flow oxygen through

nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372(23):2185–2196.

14. Zhao H, Wang H, Sun F, et al. High-flow nasal cannula oxygen therapy is superior to conventional oxygen

therapy but not to noninvasive mechanical ventilation on intubation rate: a systematic review and meta-

312

Norihito Omote et al

analysis. Crit Care. 2017;21(1):184.

15. Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias.

An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med.

2013;188(6):733–738.

16. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria

for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324.

17. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma

criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis

Rheum. 1980;23:581-590.

18. Smolen JS, Steiner G. Mixed connective tissue disease: to be or not to be? Arthritis Rheum. 1998;41:768–

777.

19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus

erythematosus. Arthritis Rheum. 1982;25:1271–1277.

20. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–347.

21. Ohtani Y, Saiki S, Kitaichi M, et al. Chronic bird fancier’s lung: histopathological and clinical correlation:

an application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax.

2005;60:665–671.

22. Camus P, Fanton A, Bonniaud P, et al. Interstitial lung disease induced by drugs and radiation. Respiration.

2004;71(4):301–326.

23. Tachikawa R, Tomii K, Ueda H, et al. Clinical features and outcome of acute exacerbation of interstitial

pneumonia: collagen vascular diseases-related versus idiopathic. Respiration. 2012;83(1):20–27.

24. Collard HR, Moore BB, Flaherty KR, et al; Idiopathic Pulmonary Fibrosis Clinical Research Network

Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med.

2007;176(7):636–643.

25. Kishaba T, Tamaki H, Shimaoka Y, et al. Staging of acute exacerbation in patients with idiopathic pulmonary

fibrosis. Lung. 2014;192(1):141–149.

26. Roca O, Sacanell J, Laborda C, et al. Cohort study on incidence of ARDS in patients admitted to the ICU

and prognostic factors of mortality. Med Intensiva. 2006;30(1):6–12.

27. Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk

factors and outcome. Eur Respir J. 2011;37(2):356–363.

28. Nishimura M. High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical

benefits, and adverse effects. Respir Care. 2016;61(4):529–541.

29. Goligher EC, Slutsky AS. Not just oxygen? Mechanisms of benefit from high-flow nasal cannula in

hypoxemic respiratory failure. Am J Respir Crit Care Med. 2017;195(9):1128–1131.

30. Frat JP, Brugiere B, Ragot S, et al. Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: an observational pilot study. Respir Care.

2015;60(2):170–178.

31. Antonelli M, Conti G, Moro ML, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med.

2001;27(11):1718–1728.

32. Delclaux C, L’Her E, Alberti C, et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency

with continuous positive airway pressure delivered by a face mask: a randomized controlled trial. JAMA.

2000;284(18):2352–2360.

33. Fernández-Pérez ER, Yilmaz M, Jenad H, et al. Ventilator settings and outcome of respiratory failure in

chronic interstitial lung disease. Chest. 2008;133(5):1113–1119.

34. Mallick S. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit.

Respir Med. 2008;102(10):1355–1359.

35. Gaudry S, Vincent F, Rabbat A, et al. Invasive mechanical ventilation in patients with fibrosing interstitial

pneumonia. J Thorac Cardiovasc Surg. 2014;147(1):47–53.

36. Ou X, Hua Y, Liu J, et al. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic

respiratory failure: a meta-analysis of randomized controlled trials. CMAJ. 2017;189:E260–267.

37. Aliberti S, Messinesi G, Gamberini S, et al. Non-invasive mechanical ventilation in patients with diffuse

interstitial lung diseases. BMC Pulm Med. 2014;14:194.

38. Abe M, Tsushima K, Matsumura T, et al. Efficacy of thrombomodulin for acute exacerbation of idiopathic

pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study. Drug Des

Devel Ther. 2015;9:5755-5562.

313

HFNC therapy for ARF due to IP

39. Burdon JG, Killian KJ, Jones NL. Pattern of breathing during exercise in patients with interstitial lung

disease. Thorax. 1983;38:778–784.

40. Maitra S, Som A, Bhattacharjee S, et al. Comparison of high-flow nasal oxygen therapy with conventional

oxygen therapy and noninvasive ventilation in adult patients with acute hypoxemic respiratory failure: a

meta-analysis and systematic review. J Crit Care. 2016;35:138–144.

41. Oishi K, Aoe K, Mimura Y, et al. Survival from an acute exacerbation of idiopathic pulmonary fibrosis with

or without direct hemoperfusion with a Ppolymyxin B-immobilized fiber column: a retrospective analysis.

Intern Med. 2016;55(24):3551–3559.

...